...
首页> 外文期刊>Metabolic syndrome and related disorders >Metabolic syndrome components are associated with future medical costs independent of cardiovascular hospitalization and incident diabetes.
【24h】

Metabolic syndrome components are associated with future medical costs independent of cardiovascular hospitalization and incident diabetes.

机译:代谢综合症的组成部分与未来的医疗费用相关,而与心血管疾病住院和糖尿病无关。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Higher medical care costs have been associated with the number of metabolic syndrome components present, but the association with future medical costs has not been described. Furthermore, the independent cost contribution of each component alone and in combination with other components is unknown. METHODS: We identified 57,420 nondiabetic adults aged >/=30 with all metabolic syndrome components measured in 2003-2004 and with 5 years of follow-up data available. We calculated and compared total annualized direct medical costs across the number of metabolic syndrome components present and for all possible combinations of metabolic syndrome components. The independent contribution to costs of each component was isolated by adjusting for age, sex, the other metabolic syndrome components, incident diabetes, number of years with diabetes, cardiovascular (CVD) hospitalization, and years after hospitalization. RESULTS: Annualized age- and sex-adjusted medical costs incurred over follow-up increased with each additional metabolic syndrome component present. After full adjustment, hypertension (Dollars 550), obesity (Dollars 366), low high-density lipoprotein (HDL) (Dollars 363), and high triglycerides (Dollars 317) were significantly associated with higher annual costs (P < 0.001 for all), but impaired fasting glucose was not. Further analysis indicated that costs were significantly elevated for each of these components only among those who did not develop diabetes or were not hospitalized for CVD. CONCLUSIONS: Incident diabetes or CVD hospitalizations accounted for the association between each metabolic syndrome component and future costs when these events occurred, but the elevated costs associated with metabolic syndrome components were observed even when these events did not occur. Further research is needed to understand the underlying morbidity that is driving the increased costs.
机译:背景:较高的医疗费用已与代谢综合征成分的数量相关联,但尚未描述与未来医疗费用的相关性。此外,每个组件单独以及与其他组件组合的独立成本贡献是未知的。方法:我们确定了2003年至2004年测量的57,420名年龄≥/ = 30岁的非糖尿病成年人的所有代谢综合征成分,并提供了5年的随访数据。我们针对存在的代谢综合征成分的数量以及所有代谢综合征成分的可能组合,计算并比较了年度直接医疗总费用。通过调整年龄,性别,其他代谢综合征的组成部分,糖尿病的发病率,糖尿病的年数,心血管病(CVD)的住院天数和住院后的年数,可以分离出每个因素对成本的独立贡献。结果:随着年龄的增长,按年龄和性别调整的医疗费用随随访时间的增加而增加。完全调整后,高血压(Dollars 550),肥胖症(Dollars 366),低密度高脂蛋白(HDL)(Dollars 363)和高甘油三酸酯(Dollars 317)与较高的年度费用显着相关(所有P均<0.001) ,但空腹血糖受损并非如此。进一步的分析表明,只有在那些未患糖尿病或未住院接受CVD的患者中,每种成分的费用均显着增加。结论:发生这些事件时,糖尿病或CVD住院治疗是每个代谢综合征成分与未来费用之间的关联,但是即使没有发生这些事件,也观察到与代谢综合征成分相关的费用增加。需要进一步研究以了解导致成本增加的潜在发病率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号